Neurocardiogenic syncope: latest pharmacological therapies

Bibliography

• FENTON AM, HAMMILL SC, REA RF, LOW PA, SHEN WK: Vasovagal syncope. Ann. Intern. Med. (2000) 133(9):714-725.
   PubMedGoogle Scholar
• GRUBB BP: Neurocardiogenic syncope. N. Engl. J. Med. (2005) 352(10):1004-1010.
   PubMed Web of Science ®Google Scholar
• CHEN-SCARABELLI C, SCARABELLI TM: Neurocardiogenic syncope. Br. Med. J. (2004) 329(7461):336-341.
   PubMedGoogle Scholar
• MOSQUEDA-GARCIA R, FURLAN R, TANK J, FERNANDEZ-VIOLANTE R: The elusive pathophysiology of neurally mediated syncope. Circulation (2000) 102(23):2898-2906.
   PubMed Web of Science ®Google Scholar
• FITZPATRICK AP, BANNER N, CHENG A, YACOUB M, SUTTON R: Vasovagal reactions may occur after orthotopic heart transplantation. J. Am. Coll. Cardiol. (1993) 21(5):1132-1137.
   PubMedGoogle Scholar
• MORILLO CA, ECKBERG DL, ELLENBOGEN KA et al.: Vagal and sympathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation (1997) 96(8):2509-2513.
   PubMed Web of Science ®Google Scholar
• BRIGNOLE M, ALBONI P, BENDITT D et al.: Guidelines on management (diagnosis and treatment) of syncope. Eur. Heart J. (2001) 22(15):1256-1306.
   PubMed Web of Science ®Google Scholar
• SAXENA PR, VILLALON CM: Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol. (1990) 15(Suppl. 7):S17-S34.
   PubMedGoogle Scholar
• FELDMAN PD, GALIANO FJ: Cardiovascular effects of serotonin in the nucleus of the solitary tract. Am. J. Physiol. (1995) 269(1 Pt 2):R48-R56.
   Google Scholar
• GRUBB BP, KARAS BJ: The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances. J. Interv. Card. Electrophysiol. (1998) 2(4):325-332.
   PubMed Web of Science ®Google Scholar
• SAMOIL D, GRUBB BP: Neurally mediated syncope and serotonin reuptake inhibitors. Clin. Auton. Res. (1995) 5(5):251-255.
   PubMedGoogle Scholar
• FLEVARI P, LIVANIS EG, THEODORAKIS GN et al.: Vasovagal syncope: a prospective, randomized, crossover evaluation of the effect of propranolol, nadolol and placebo on syncope recurrence and patients’ well-being. J. Am. Coll. Cardiol. (2002) 40(3):499-504.
   PubMed Web of Science ®Google Scholar
• LINZER M, PONTINEN M, GOLD DT et al.: Impairment of physical and psychosocial function in recurrent syncope. J. Clin. Epidemiol. (1991) 44(10):1037-1043.
   PubMed Web of Science ®Google Scholar
• LINZER M, GOLD DT, PONTINEN M et al.: Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment. J. Gen. Intern. Med. (1994) 9(4):181-186.
   PubMed Web of Science ®Google Scholar
• KAPOOR WN: Evaluation and outcome of patients with syncope. Medicine (1990) 69(3):160-175.
   PubMed Web of Science ®Google Scholar
• KAPOOR WN, KARPF M, WIEAND S, PETERSON JR, LEVEY GS: A prospective evaluation and follow-up of patients with syncope. N. Engl. J. Med (1983) 309(4):197-204.
   PubMed Web of Science ®Google Scholar
• COX MM, PERLMAN BA, MAYOR MR et al.: Acute and long-term β-adrenergic blockade for patients with neurocardiogenic syncope. J. Am. Coll. Cardiol. (1995) 26(5):1293-1298.
   PubMed Web of Science ®Google Scholar
• COHEN MB, SNOW JS, GRASSO V et al.: Efficacy of pindolol for treatment of vasovagal syncope. Am. Heart J. (1995) 130(4):786-790.
   PubMed Web of Science ®Google Scholar
• MULLER G, DEAL BJ, STRASBURGER JF, BENSON DW Jr: Usefulness of metoprolol for unexplained syncope and positive response to tilt testing in young persons. Am. J. Cardiol. (1993) 71(7):592-595.
   PubMed Web of Science ®Google Scholar
• ISKOS D, DUTTON J, SCHEINMAN MM, LURIE KG: Usefulness of pindolol in neurocardiogenic syncope. Am. J. Cardiol. (1998) 82(9):1121-1124.
   PubMed Web of Science ®Google Scholar
• VENTURA R, MAAS R, ZEIDLER D et al.: A randomized and controlled pilot trial of β-blockers for the treatment of recurrent syncope in patients with a positive or negative response to head-up tilt test. Pacing Clin. Electrophysiol. (2002) 25(5):816-821.
   PubMed Web of Science ®Google Scholar
• MAHANONDA N, BHURIPANYO K, KANGKAGATE C et al.: Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am. Heart J. (1995) 130(6):1250-1253.
   PubMed Web of Science ®Google Scholar
• FITZPATRICK AP, AHMED S, WILLIAMS S, SUTTON R: A randomised trial of medical therapy in ‘malignant vasovagal syndrome’ or ‘neurally-mediated bradycardia/hypotension syndrome’. Eur. J. Cardiac Electrophysiol. (1991) 1(2):99-102.
   Google Scholar
• MADRID AH, ORTEGA J, REBOLLO JG et al.: Lack of efficacy of atenolol for the prevention of neurally mediated syncope in a highly symptomatic population: a prospective, double-blind, randomized and placebo-controlled study. J. Am. Coll. Cardiol. (2001) 37(2):554-559.
   PubMed Web of Science ®Google Scholar
• MOYA A, PERMANYER-MIRALDA G, SAGRISTA-SAULEDA J et al.: Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo. J. Am. Coll. Cardiol. (1995) 25(1):65-69.
   PubMed Web of Science ®Google Scholar
• SHELDON R, CONNOLLY S, ROSE S et al.: Prevention of Syncope Trial (POST): a randomized, placebo-controlled study of metoprolol in the prevention of vasovagal syncope. Circulation (2006) 113(9):1164-1170.
   PubMed Web of Science ®Google Scholar
• DENDI R, GOLDSTEIN DS: Meta-analysis of nonselective versus β1 adrenoceptor-selective blockade in prevention of tilt-induced neurocardiogenic syncope. Am. J. Cardiol. (2002) 89(11):1319-1321.
   PubMed Web of Science ®Google Scholar
• THE TASK FORCE ON SYNCOPE ESOC: Guidelines on management (diagnosis and treatment) of syncope – update 2004. Europace (2004) 6(6):467-537.
   PubMed Web of Science ®Google Scholar
• LOW PA, GILDEN JL, FREEMAN R, SHENG KN, MCELLIGOTT MA: Efficacy of midodrine versus placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. JAMA (1997) 277(13):1046-1051.
   PubMed Web of Science ®Google Scholar
• KAUFMANN H, BRANNAN T, KRAKOFF L, YAHR MD, MANDELI J: Treatment of orthostatic hypotension due to autonomic failure with a peripheral α-adrenergic agonist (midodrine). Neurology (1988) 38(6):951-956.
   PubMedGoogle Scholar
• KAUFMANN H, SAADIA D, VOUSTIANIOUK A: Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study. Ann. Neurol. (2002) 52(3):342-345.
   PubMed Web of Science ®Google Scholar
• WARD CR, GRAY JC, GILROY JJ, KENNY RA: Midodrine: a role in the management of neurocardiogenic syncope. Heart (1998) 79(1):45-49.
   PubMed Web of Science ®Google Scholar
• PEREZ-LUGONES A, SCHWEIKERT R, PAVIA S et al.: Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study. J. Cardiovasc. Electrophysiol. (2001) 12(8):935-938.
   PubMed Web of Science ®Google Scholar
• RAVIELE A, BRIGNOLE M, SUTTON R et al.: Effect of etilefrine in preventing syncopal recurrence in patients with vasovagal syncope: a double-blind, randomized, placebo-controlled trial. The Vasovagal Syncope International Study. Circulation (1999) 99(11):1452-1457.
   PubMed Web of Science ®Google Scholar
• RAVIELE A, GASPARINI G, DI PEDE F et al.: Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am. J. Cardiol. (1990) 65(20):1322-1327.
   PubMed Web of Science ®Google Scholar
• GRUBB B, KOSINSKI D: Serotonin and syncope: an emerging connection? Eur. J. Cardiac Pacing Electorphysiol. (1996) 5:306-314.
   Google Scholar
• KUHN D, WOLF W, LOVENBERG W: Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension (1980) 2(3):243-255.
   PubMed Web of Science ®Google Scholar
• ELAM R, BERGMANN F, FEUERSTEIN G: The use of anti-serotonergic agents for the treatment of acute hemorrhagic shock of cats. Eur. J. Pharmacol. (1985) 107:275-278.
   PubMedGoogle Scholar
• GRUBB BP, WOLFE DA, SAMOIL D et al.: Usefulness of fluoxetine hydrochloride for prevention of resistant upright tilt induced syncope. Pacing Clin. Electrophysiol. (1993) 16(3 Pt 1):458-464.
   PubMed Web of Science ®Google Scholar
• GRUBB BP, SAMOIL D, KOSINSKI D, KIP K, BREWSTER P: Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J. Am. Coll. Cardiol. (1994) 24(2):490-494.
   PubMed Web of Science ®Google Scholar
• DI GIROLAMO E, DI IORIO C, SABATINI P et al.: Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J. Am. Coll. Cardiol. (1999) 33(5):1227-1230.
   PubMed Web of Science ®Google Scholar
• TAKATA TS, WASMUND SL, SMITH ML et al.: Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation (2002) 106(12):1500-1504.
   PubMed Web of Science ®Google Scholar
• SCHIMMER B, PARKER K: Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs: inhibitors of the synthesis and actions of adrenocortical hormones. In: Goodman and Gillman’s The Pharmacological Basis of Therapeutics, JG Hardman, LE Limbird, PB Molinoff, RW Ruddon, AG Gilman (Eds), McGraw-Hill, New York, NY, USA (2001):1649-1677.
   Google Scholar
• SCOTT WA, PONGIGLIONE G, BROMBERG BI et al.: Randomized comparison of atenolol and fludrocortisone acetate in the treatment of pediatric neurally mediated syncope. Am. J. Cardiol. (1995) 76(5):400-402.
   PubMed Web of Science ®Google Scholar
• DA COSTA D, MCINTOSH S, KENNY RA: Benefits of fludrocortisone in the treatment of symptomatic vasodepressor carotid sinus syndrome. Br. Heart J. (1993) 69(4):308-310.
   PubMed Web of Science ®Google Scholar
• HUSSAIN RM, MCINTOSH SJ, LAWSON J, KENNY RA: Fludrocortisone in the treatment of hypotensive disorders in the elderly. Heart (1996) 76(6):507-509.
   PubMed Web of Science ®Google Scholar
• KELLY PA, MANN DE, ADLER SW, FUENZALIDA CE, REITER MJ: Low dose disopyramide often fails to prevent neurogenic syncope during head-up tilt testing. Pacing Clin. Electrophysiol. (1994) 17(4 Pt 1):573-576.
   PubMedGoogle Scholar
• MILSTEIN S, BUETIKOFER J, DUNNIGAN A et al.: Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. Am. J. Cardiol. (1990) 65(20):1339-1344.
   PubMed Web of Science ®Google Scholar
• MORILLO CA, LEITCH JW, YEE R, KLEIN GJ: A placebo-controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope induced by head-up tilt. J. Am. Coll. Cardiol. (1993) 22(7):1843-1848.
   PubMed Web of Science ®Google Scholar
• WIELING W, VAN LIESHOUT JJ, HAINSWORTH R: Extracellular fluid volume expansion in patients with posturally related syncope. Clin. Auton. Res. (2002) 12(4):242-249.
   PubMed Web of Science ®Google Scholar
• EL-SAYED H, HAINSWORTH R: Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope. Heart (1996) 75(2):134-140.
   PubMed Web of Science ®Google Scholar
• ABE H, SUMIYOSHI M, KOHSHI K, NAKASHIMA Y: Effects of orthostatic self-training on head-up tilt testing for the prevention of tilt-induced neurocardiogenic syncope: comparison of pharmacological therapy. Clin. Exp. Hypertens. (2003) 25(3):191-198.
   PubMed Web of Science ®Google Scholar
• KREDIET CT, VAN DIJK N, LINZER M, VAN LIESHOUT JJ, WIELING W: Management of vasovagal syncope: controlling or aborting faints by leg crossing and muscle tensing. Circulation (2002) 106(13):1684-1689.
   PubMed Web of Science ®Google Scholar
• BRIGNOLE M, CROCI F, MENOZZI C et al.: Isometric arm counter-pressure maneuvers to abort impending vasovagal syncope. J. Am. Coll. Cardiol. (2002) 40(11):2053-2059.
   PubMed Web of Science ®Google Scholar
• LEE TM, SU SF, CHEN MF, LIAU CS, LEE YT: Usefulness of transdermal scopolamine for vasovagal syncope. Am. J. Cardiol. (1996) 78(4):480-482.
   PubMed Web of Science ®Google Scholar
• GRUBB BP, KOSINSKI D, MOUHAFFEL A, POTHOULAKIS A: The use of methylphenidate in the treatment of refractory neurocardiogenic syncope. Pacing Clin. Electrophysiol. (1996) 19(5):836-840.
   PubMed Web of Science ®Google Scholar
• NELSON SD, STANLEY M, LOVE CJ, COYNE KS, SCHAAL SF: The autonomic and hemodynamic effects of oral theophylline in patients with vasodepressor syncope. Arch. Intern. Med. (1991) 151(12):2425-2429.
   PubMedGoogle Scholar
• SHELDON R, ROSE S, CONNOLLY S: Prevention of Syncope Trial (POST): a randomized clinical trial of β blockers in the prevention of vasovagal syncope; rationale and study design. Europace (2003) 5(1):71-75.
   PubMed Web of Science ®Google Scholar
• BRIGNOLE M, MENOZZI C, GIANFRANCHI L et al.: A controlled trial of acute and long-term medical therapy in tilt-induced neurally mediated syncope. Am. J. Cardiol. (1992) 70(3):339-342.
   PubMed Web of Science ®Google Scholar